| 1 |
2021 |
Eduardo Tosta, The adaptation of SARS-CoV-2 to humans, Memórias do Instituto Oswaldo Cruz. 2021; 116: e210127.
https://doi.org/10.1590/0074-02760210127 |
| 2 |
2022 |
Challika Kaewborisuth, Asawin Wanitchang, Surapong Koonpaew, Kanjana Srisutthisamphan, Janya Saenboonrueng, Rawiwan Im-Erbsin, Manutsanun Inthawong, Piyanate Sunyakumthorn, Theeradej Thaweerattanasinp, Nathiphat Tanwattana, Yuparat Jantraphakorn, Matthew C. Reed, Luis A. Lugo-Roman, Taweewun Hunsawong, Chonticha Klungthong, Anthony R. Jones, Stefan Fernandez, Samaporn Teeravechyan, Eric D. Lombardini, Anan Jongkaewwattana. Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice, Vaccines. 2022; 10: 786.
https://doi.org/10.3390/vaccines10050786 |
| 3 |
2022 |
Irina Chikileva, Irina Shubina, Anzhelika-Mariia Burtseva, Kirill Kirgizov, Nara Stepanyan, Svetlana Varfolomeeva, Mikhail Kiselevskiy. Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents, Biomedicines. 2022; 10: 868.
https://doi.org/10.3390/biomedicines10040868 |
| 4 |
2022 |
I. O. Chikileva, I. Zh. Shubina, M. V. Kiselevskiy. Modern antiviral biomedical cell products and their applications for COVID-19 therapy, Russian Journal of Biotherapy. 2022; 21: 19.
https://doi.org/10.17650/1726-9784-2022-21-2-19-32 |
| 5 |
2021 |
Eduardo Tosta, The seven constitutive respiratory defense barriers against SARS-CoV-2 infection, Revista da Sociedade Brasileira de Medicina Tropical. 2021; 54: e0461-2021.
https://doi.org/10.1590/0037-8682-0461-2021 |
